Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

• Главные авторы: Tarride JE (Автор), Burke N (Автор), Von Keyserlingk C (Автор), O'Reilly D (Автор), Xie F (Автор), Goeree R (Автор)
• Формат: ‌
• Опубликовано: Dove Medical Press, 2012-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Jean-Eric Tarride,1,2 Natasha Burke,1,2 Camilla Von Keyserlingk,1,2 Daria O'Reilly,1,2 Feng Xie,1,2 Ron Goeree1,21Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph's Healthcare Hamilton, Hamilton, 2Department of Clinical Epidemiology and Biostatisti...